ciltacabtagene autoleucel
Janssen
['mmsm']
the overall response rate per independent review committee was 97.9% (95% ci, 92.7%-99.7%), which included 82.5% (95% ci, 73.4%-89.4%) of patients experiencing a stringent complete response. #mmsm #eha2020 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.